evolcSign inStart free
Menu

Ilc Therapeutics

Develops hybrid interferon therapeutics, with lead candidate Alfacyte in development as an antiviral for RSV

Edinburgh, United KingdomFounded 2012ilctherapeutics.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Ilc Therapeutics

ILC Therapeutics is a cytokine-engineering company developing Hybrid Interferons, a new drug class engineered to target specific diseases. Its lead candidate, Alfacyte, is a broad-spectrum antiviral in development as a therapeutic for RSV.

The company develops drug candidates for diseases with large unmet medical need and a clear commercial market.

ILC Therapeutics Ltd is registered in Edinburgh, United Kingdom, and was founded in 2012. In September 2024 it announced a £2.5m fundraise.

Product: Alfacyte, a broad-spectrum antiviral hybrid interferon in development for RSV; a platform for engineering Hybrid Interferons.

Jobs at Ilc Therapeutics

No open positions listed right now.

More biotech & pharma companies

  • IMU Biosciences

    Immune profiling and precision-medicine tools for clinical research, pharmaceutical, biotech and diagnostics organizations
    United KingdomBiotech & pharma1 open job
    Remote-friendly

  • Infectopharm

    Pharmaceutical products for healthcare providers and distribution partners in the UK market
    Marlow, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

  • Invox Pharma

    Develops respiratory medicines and soft-mist inhaler products for patients and pharmaceutical partners
    London, United KingdomBiotech & pharmaFounded 2021
    New on Evolc

  • Ipsen

    Develops and sells medicines in oncology, rare diseases and neuroscience for patients and healthcare professionals
    London, United KingdomBiotech & pharmaFounded 2008147 open jobs
    New on Evolc

  • Isomorphic Labs

    AI-driven drug discovery platform building predictive and generative models for pharmaceutical research and development
    London, United KingdomBiotech & pharmaFounded 202132 open jobs
    Remote-friendly

  • Istesso

    Develops oral mitochondrial Complex I modulator medicines to restore tissue repair; lead candidate leramistat is in Phase 2
    London, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Bootstrap
  • jQuery
  • nginx